Beta Connect

How the words we use affect our diabetes care -

How the Words We Use Affect Our Diabetes Care Person living with diabetes vs. diabetic, non-compliant vs. uncontrolled — the words we say about diabetes affect our perceptions of the disease.

Check out the Diabetes Mine article featuring Heather Gabel of Beta Connect! http://www.diabetesmine.com/2014/08/patient-voices-winner-heather-gabel-puts-on-many-advocacy-hats.html

Patient Voices Winner Heather Gabel Puts On Many Advocacy Hats We’re happy to feature one more of our 2014 DiabetesMine Patient Voices Scholarship Contest winners today -- another empowered advocate who'll be attending our Innovation Summit in November. Meet fellow type 1 Heather Gabel, who's been featured here at the 'Mine during the past year thanks to all he…

Please join us for a symposium for children with Type 1 diabetes. Children and teens, along with their families, and those who care for children with Type 1 diabetes will learn about the latest diabetes research, coping with diabetes, and developmental stages of children living with Type 1 diabetes. The entire family is welcome! Screening for the TrialNet Pathway to Prevention Study will be offered as well. http://bitly.com/1kZ4wMS Symposium: Thursday, September 04, 2014, 6 PM - 8:30 PM, San Ramon Community Center More at: http://bitly.com/YFOtJK

Patients with Type 1 Diabetes and their Families | Events | UCSF Benioff Children's Hospital Oakland Symposium for people with type 1 diabetes and their families. Topics covered will address, diabetes research, coping with diabetes and developmental stages of children living with type 1 diabetes. Screening for the TrialNet Pathway to Prevention Study will be offered as well.

Miss Idaho decided not to hide the insulin pump she wears to treat Type 1 diabetes during the pageant.

Hey, Miss Idaho, Is That An Insulin Pump On Your Bikini? Sierra Sandison couldn't imagine how she would hide an insulin pump during beauty pageants. So she decided to show it off for the Miss Idaho pageant. She won. Type 1 diabetics say they won, too.

Re: -A “bionic pancreas”—a wearable, automated, device that offers diabetic patients better glycemic control than the current standard of care in patients with type 1 diabetes—may be in your future. According to studies published in the (New England Journal of Medicine) the device is "investigational" which means it is now being tested in clinical trials. Though the safety and effectiveness of a bionic pancreas has not been tested in unrestricted outpatient conditions, a study published in the NEJM found that compared with an insulin pump, a wearable, automated, bihormonal, "bionic pancreas" improved mean glycemic levels, with less frequent hypoglycemic episodes among adolescents with type 1 diabetes mellitus. NEJM-JournalWatch: http://bitly.com/1q553eX

Re: -A “bionic pancreas”—a wearable, automated, device that offers diabetic patients better glycemic control than the current standard of care in patients with type 1 diabetes—may be in your future. According to studies published in the (New England Journal of Medicine) the device is "investigational" which means it is now being tested in clinical trials. Though the safety and effectiveness of a bionic pancreas has not been tested in unrestricted outpatient conditions, a study published in the NEJM found that compared with an insulin pump, a wearable, automated, bihormonal, "bionic pancreas" improved mean glycemic levels, with less frequent hypoglycemic episodes among adolescents with type 1 diabetes mellitus. NEJM-JournalWatch: http://bitly.com/1q553eX

Sarah Afzal speaking about Beta Connect and the importance of addressing the psychological and psychosocial issues that affect the management and care of Type 1 diabetes in youth at the diabetes educator conference at UCSF.

At Insulliance, one of the concerns young children and families of young children with Type 1 diabetes express is difficulty identifying symptoms of high and low blood sugar. We are thrilled to announce that the FDA has approved the Dexcom G4 Platinum Continuous Monitoring (CGM) System for use in the pediatric population. CGMs are equipped with alarms to alert those wearing the device of hyperglycemia or hypoglycemia. What does this news mean to you and/or your family?

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm384495.htm

FDA approves pediatric use of Dexcom’s G4 Platinum continuous glucose monitoring system The U.S. Food and Drug Administration today approved the expanded use of the Dexcom G4 Platinum Continuous Monitoring System for patients with diabetes ages 2 to 17 years. The G4 Platinum System, which monitors blood glucose levels in people with diabetes, had been approved for patients ages 18 and…